492 related articles for article (PubMed ID: 19094855)
1. Case report: a case of pyoderma gangrenosum with intractable leg ulcers treated by allogeneic cultured dermal substitutes.
Toyozawa S; Yamamoto Y; Nishide T; Kishioka A; Kanazawa N; Matsumoto Y; Kuroyanagi Y; Furukawa F
Dermatol Online J; 2008 Nov; 14(11):17. PubMed ID: 19094855
[TBL] [Abstract][Full Text] [Related]
2. Clinical study with allogeneic cultured dermal substitutes for chronic leg ulcers.
Yonezawa M; Tanizaki H; Inoguchi N; Ishida M; Katoh M; Tachibana T; Miyachi Y; Kubo K; Kuroyanagi Y
Int J Dermatol; 2007 Jan; 46(1):36-42. PubMed ID: 17214717
[TBL] [Abstract][Full Text] [Related]
3. Accelerated healing of pyoderma gangrenosum treated with bioengineered skin and concomitant immunosuppression.
de Imus G; Golomb C; Wilkel C; Tsoukas M; Nowak M; Falanga V
J Am Acad Dermatol; 2001 Jan; 44(1):61-6. PubMed ID: 11148478
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of allogeneic cultured dermal substitutes for intractable skin ulcers after tumor resection.
Moroi Y; Fujita S; Fukagawa S; Mashino T; Goto T; Masuda T; Urabe K; Kubo K; Matsui H; Kagawa S; Kuroyanagi Y; Furue M
Eur J Dermatol; 2004; 14(3):172-6. PubMed ID: 15246944
[TBL] [Abstract][Full Text] [Related]
5. Effective treatment of intractable skin ulcers using allogeneic cultured dermal substitutes in patients with systemic lupus erythematosus.
Toyozawa S; Yamamoto Y; Kishioka A; Yonei N; Kanazawa N; Matsumoto Y; Kuroyanagi Y; Furukawa F
Eur J Dermatol; 2009; 19(6):594-6. PubMed ID: 19666399
[TBL] [Abstract][Full Text] [Related]
6. Accelerated healing of pyoderma gangrenosum in Behçet patient treated with cyclosporine and split thickness skin graft.
Kim DW; Lee BI; Park SH
Ann Plast Surg; 2008 Nov; 61(5):552-4. PubMed ID: 18948785
[TBL] [Abstract][Full Text] [Related]
7. Pyoderma gangrenosum requiring inpatient management: a report of 26 cases with follow up.
Saracino A; Kelly R; Liew D; Chong A
Australas J Dermatol; 2011 Aug; 52(3):218-21. PubMed ID: 21834821
[TBL] [Abstract][Full Text] [Related]
8. An allogeneic cultured dermal substitute suitable for treating intractable skin ulcers and large skin defects prior to autologous skin grafting: three case reports.
Hasegawa T; Suga Y; Mizoguchi M; Muramatsu S; Mizuno Y; Ogawa H; Kubo K; Kuroyanagi Y
J Dermatol; 2005 Sep; 32(9):715-20. PubMed ID: 16361714
[TBL] [Abstract][Full Text] [Related]
9. [Topical negative pressure and skin transplantation for the treatment of pyoderma gangrenosum].
Gámiz RC; Nielsen AM
Ugeskr Laeger; 2011 Aug; 173(35):2132-3. PubMed ID: 21884666
[TBL] [Abstract][Full Text] [Related]
10. A case report of steroid and immunosuppressant-resistant pyoderma gangrenosum successfully treated by granulocytapheresis.
Okuma K; Mitsuishi K; Hasegawa T; Tsuchihashi H; Ogawa H; Ikeda S
Ther Apher Dial; 2007 Oct; 11(5):387-90. PubMed ID: 17845399
[TBL] [Abstract][Full Text] [Related]
11. Viability and function of autologous and allogeneic fibroblasts seeded in dermal substitutes after implantation.
Morimoto N; Saso Y; Tomihata K; Taira T; Takahashi Y; Ohta M; Suzuki S
J Surg Res; 2005 May; 125(1):56-67. PubMed ID: 15836851
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of conservative medical treatment for pyoderma gangrenosum.
Fioramonti P; Onesti MG; Fino P; Di Ronza S; Sorvillo V; Persichetti P
In Vivo; 2012; 26(1):157-9. PubMed ID: 22210732
[TBL] [Abstract][Full Text] [Related]
13. [Autodermoplasty with split skin grafts in treatment of pyoderma gangrenosum].
Andreev DIu
Vestn Khir Im I I Grek; 2011; 170(1):72-5. PubMed ID: 21506362
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of dermoplasty and the dermal equivalent in treatment of vast leg ulcers of mixed genesis].
Andreev DIu; Abramova NV; Blinova MI; Pinaev GP
Vestn Khir Im I I Grek; 2013; 172(1):104-7. PubMed ID: 23808240
[TBL] [Abstract][Full Text] [Related]
15. Treatment of intractable skin ulcers caused by vascular insufficiency with allogeneic cultured dermal substitute: a report of eight cases.
Taniguchi T; Amoh Y; Tanabe K; Katsuoka K; Kuroyanagi Y
J Artif Organs; 2012 Mar; 15(1):77-82. PubMed ID: 21861088
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of wound breakdown caused by pyoderma gangrenosum after total knee arthroplasty.
Nakajima N; Ikeuchi M; Izumi M; Kuriyama M; Nakajima H; Tani T
Knee; 2011 Dec; 18(6):453-5. PubMed ID: 20643552
[TBL] [Abstract][Full Text] [Related]
17. Treatment of full-thickness skin defect with concomitant grafting of 6-fold extended mesh auto-skin and allogeneic cultured dermal substitute.
Kashiwa N; Ito O; Ueda T; Kubo K; Matsui H; Kuroyanagi Y
Artif Organs; 2004 May; 28(5):444-50. PubMed ID: 15113338
[TBL] [Abstract][Full Text] [Related]
18. Pyoderma gangrenosum as initial manifestation of Graves' disease.
Livideanu C; Lipsker D; Paul C; Juillard J; Schubert B
Clin Exp Dermatol; 2006 Sep; 31(5):659-61. PubMed ID: 16780496
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of granulocyte and monocyte adsorption apheresis for three cases of refractory pyoderma gangrenosum.
Seishima M; Mizutani Y; Shibuya Y; Nagasawa C; Aoki T
Ther Apher Dial; 2007 Jun; 11(3):177-82. PubMed ID: 17497998
[TBL] [Abstract][Full Text] [Related]
20. The management of leg ulcers in a patient with ulcerative colitis. This case study details the treatment of a patient with pyoderma gangrenosum on the shins of both legs.
Nelson EA; Gibson B
J Wound Care; 1995 Oct; 4(9):391-3. PubMed ID: 7584656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
